PCNA and breast neoplasm: For example, ALDH+ breast tumors display higher proportion of proliferation marker PCNA and a worse clinical outcome (Gong et al., 2010) while Ki-67+, another classical proliferation marker, is essential for the functional characteristics of BCSC (Cidado et al., 2016).